Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Vitamin D receptor deficiency promotes LPS-induced systemic inflammation and Alum-induced peritoneal inflammation via suppression of the NLRP3 inflammasome. (A) Survival of VDR+/+NLRP3+/+, VDR−/−NLRP3+/+, VDR+/+NLRP3−/−, and VDR−/−NLRP3−/− mice (n = 10 mice/group) intraperitoneally injected with LPS (8 mg/kg body weight) over a period of 72 h. (B: D) Serum IL-1β, IL-18, and TNFα ELISAs at 6 h after intraperitoneal injection of LPS (8 mg/kg body weight) into VDR+/+NLRP3+/+, VDR−/−NLRP3+/+, VDR+/+NLRP3−/−, and VDR−/−NLRP3−/− mice. (E,F) Representative FACS plots of peritoneal CD11b+ Ly6G+ cells (neutrophils) from VDR+/+NLRP3+/+, VDR−/−NLRP3+/+, VDR+/+NLRP3−/−, and VDR−/−NLRP3−/− mice at 12 h after an intraperitoneal injection with alum (n = 5 mice/group). *p < 0.05, **p < 0.01, ***p < 0.001, NS p > 0.05.
Source: VDR Deficiency Promotes NLRP3-Mediated Inflammation in vivo. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Nlrp3−/−i mice were a kind gift from Dr.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Vitamin D Receptor Inhibits NLRP3 Activation by Impeding Its BRCC3-Mediated Deubiquitination
Study design awaiting verification · Frontiers in Immunology · 2019
Original publication title
Vitamin D Receptor Inhibits NLRP3 Activation by Impeding Its BRCC3-Mediated Deubiquitination
Copyright © 2019 Rao, Chen, Wu, Xiao, Zhang, Wang, Fang, Zhang, Wang, Yang and Chen.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
The NLRP3 inflammasome is a multiprotein oligomer responsible for activation of the inflammatory response by promoting the maturation and secretion of the pro-inflammatory cytokines IL-1β and IL-18. Dysregulation of this inflammasome has been linked to several autoimmune diseases, indicating that NLRP3 is tightly regulated to prevent aberrant activation. The regulation of NLRP3 activation remains unclear. Here, we report the identification of vitamin D receptor (VDR) as a negative regulator of NLRP3 oligomerization and activation. VDR can physically bind NLRP3 and block the association of NLRP3 with BRCC3.
When BRCC3-mediated deubiquitination of NLRP3 is inhibited by VDR, NLRP3 activation is subsequently inhibited. In the absence of VDR, caspase-1 activation and IL-1β release are increased in response to LPS-induced inflammation or alum-induced peritoneal inflammation, indicating that VDR is a negative regulator of NLRP3 inflammasome activation in vivo. In addition, vitamin D negatively regulates the NLRP3 inflammasome via VDR signaling to effectively inhibit IL-1β secretion. These studies demonstrate that VDR signaling constrains NLRP3 inflammasome activation and might be a potential treatment target for NLRP3 inflammasome-related diseases.
Authors’ abstract
The NLRP3 inflammasome is a multiprotein oligomer responsible for activation of the inflammatory response by promoting the maturation and secretion of the pro-inflammatory cytokines IL-1β and IL-18. Dysregulation of this inflammasome has been linked to several autoimmune diseases, indicating that NLRP3 is tightly regulated to prevent aberrant activation. The regulation of NLRP3 activation remains unclear. Here, we report the identification of vitamin D receptor (VDR) as a negative regulator of NLRP3 oligomerization and activation. VDR can physically bind NLRP3 and block the association of NLRP3 with BRCC3.
When BRCC3-mediated deubiquitination of NLRP3 is inhibited by VDR, NLRP3 activation is subsequently inhibited. In the absence of VDR, caspase-1 activation and IL-1β release are increased in response to LPS-induced inflammation or alum-induced peritoneal inflammation, indicating that VDR is a negative regulator of NLRP3 inflammasome activation in vivo. In addition, vitamin D negatively regulates the NLRP3 inflammasome via VDR signaling to effectively inhibit IL-1β secretion. These studies demonstrate that VDR signaling constrains NLRP3 inflammasome activation and might be a potential treatment target for NLRP3 inflammasome-related diseases.
Publication and source details
Original title: Vitamin D Receptor Inhibits NLRP3 Activation by Impeding Its BRCC3-Mediated Deubiquitination
Zebing Rao; Xin Chen; Junxian Wu; Mengjun Xiao; Jing Zhang; Binghao Wang; Lei Fang; Hongjie Zhang; Xiaoming Wang; Shuo Yang; Yunzi Chen
Frontiers in Immunology · 2019
Edited by: Francesca Granucci, University of Milano Bicocca, Italy
Reviewed by: Johanna Hol Fosse, Norwegian Veterinary Institute, Norway; Chaofeng Han, Second Military Medical University, China
This article was submitted to Molecular Innate Immunity, a section of the journal Frontiers in Immunology
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T03:21:06.750097+00:00
DOI: 10.3389/fimmu.2019.02783 · PMC6904361